Genetic screening in reproductive health care

被引：12

作者：

Mennuti, Michael T. ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2008年 / 51卷 / 01期

关键词：

genetic screening; cystic fibrosis;

D O I：

10.1097/GRF.0b013e318160f241

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Genetic screening is used to identify individuals who have genetic variations or mutations that are associated with a particular disorder. Genetic screening may be useful to plan for periodic evaluation, implementation of preventive strategies, or initiation of therapeutic interventions. Current practice is to offer carrier screening for certain genetic diseases during the preconception encounter or more commonly as part of early prenatal care.

引用

页码：3 / 23

页数：21

共 21 条

[1]

*ACOG, 2001, PREC PRENT CARR SCRE

[2]

*ACOG, 2005, ACOG PRACT B, V64, P802

[3]

ACOG Committee on Genetics, 2004, Obstet Gynecol, V104, P425

[4]

[Anonymous], OBSTET GYNECOL

[5]

Branda KJ, 2004, GENET TEST, V8, P174, DOI 10.1089/gte.2004.8.174

[6]

Committee on Genetics American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P1465

[7]

*CYST FIBR FDN, PAT REG 2004 ANN REP

[8] Cardiomyopathy in a carrier of Duchenne's muscular dystrophy [J].

Davies, JE ;

Winokur, TS ;

Aaron, MF ;

Benza, RL ;

Foley, BA ;

Holman, WL .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (07) :781-784

[9]

*FDS, 2006, FDA CONS, V40, P16

[10]

HECHTMAN P, 1990, AM J HUM GENET, V47, P815

← 1 2 3 →